Assetmark, Inc Meridian Bioscience Inc Transaction History

Assetmark, Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 01, 2022	BUY	$30.9 - $33.55 $61 - $67	2 Added 2.86%	72 $2,000
Q1 2022 May 13, 2022	BUY	$19.97 - $26.94 $179 - $242	9 Added 14.75%	70 $2,000
Q3 2021 Nov 12, 2021	SELL	$17.35 - $22.5 $470,636 - $610,335	-27,126 Reduced 99.78%	61 $1,000
Q2 2021 Aug 16, 2021	BUY	$18.01 - $28.32 $52,787 - $83,005	2,931 Added 12.08%	27,187 $603,000
Q1 2021 May 14, 2021	BUY	$19.76 - $29.89 $479,298 - $725,011	24,256 New	24,256 $637,000
Q1 2018 May 16, 2018	SELL	$13.8 - $16.2 $855 - $1,004	-62 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$13.55 - $15.8 $840 - $979	62	62 $1,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

Stay updated on Assetmark, Inc with notifications on news.